{"name":"Asher Biotherapeutics, Inc.","slug":"asher-biotherapeutics-inc","ticker":"","exchange":"","domain":"asherbiotherapeutics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9zc2ZscXVYNE54d2ZxbW9UcVBXQzFMWWRuLS1SbklQMzk4N2dkWjh5TFFHaHM1bE44c1BQLTh0Y1R4LWZWSGM5VjlPQ2p6ZW1hNTdJZ05YWHJzYkVnenhTR29iZFBnbFUtcV9HNmtPN2hYMEltenhGVlJxWQ?oc=5","date":"2024-11-07","type":"pipeline","source":"BioCentury","summary":"Celltex names Anita Perry CEO - BioCentury","headline":"Celltex names Anita Perry CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNdlcyRzc0UWU5ZHpXLUdsd1BFcFpKTkRuTl9xQkNoQVozR3ZTVkszMU1OdWJqb0ptR05TNHJfbFZaVFBxUlkyWkM5Sm96S1psbXNoVzlyeXRUM2FRMG53TGhVRHlna1B6c2x2UU93QzVySFA3UWJnX3pJYkRWNWRDeUI3UjVXZGdRbVRiV01RcmNrLURjVTYyWEp3dlpDUFBTaGh4aTR4dGdDbUQ0czhFNHhadnRleXRXOEdSRFBkOA?oc=5","date":"2024-06-04","type":"pipeline","source":"Healio","summary":"Durvalumab extends survival in limited-stage small-cell lung cancer - Healio","headline":"Durvalumab extends survival in limited-stage small-cell lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOTnlzYjlVaE9pVGk2YXlCLWdWZFVnVjhRU0RVZ0NYRnA5a3F2eUFGa0JrRFpRUkUzV1QyeEZMLWI1YzNrNlBuZ0xZaVM0Z3JLelZtdTFVQjhwNTh2Y2dReU4tQ0lvd0gxWHBMS2FhdFdfLVhzaUxTLTFWYWRyTE0yZ3hSaU5HLWNQSVp2a3MydWRDSFp1b2tqYkFXZTBHSnRJN3VjV3ZKVkxSWXZBOXYxN09NUjRhbnhoUGhhODBsZ0JUX2tVaW05cHNxcmNISVBtb3hteU45MjRRNTc5NXdlYXR5SmtWSllVV0RwZlJ2QnNIQQ?oc=5","date":"2024-04-16","type":"trial","source":"Business Wire","summary":"Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials - Business Wire","headline":"Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONjI2THYyOU9rbVhMMDRXU1JWNF9zcjRaT0R2TXR3SU5iQTktN1FYTlY1YzQzSkstRVFGZGxsOWg1RThVWENZTkRmemYyMEhBZzZFWUJZZ2h1YVJzN1NKaVpBSmMzWEU0TXlUbVhaZ0JtLTZDZmxiM1JEU1dBcU1PMg?oc=5","date":"2024-01-04","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPZnpIc09lalQ4U1dHMVlJYXNyNm9HelhyTEU4akFnMjcwY25wWW1EdXZmRVZScmhFaHR2b2toNjd0SURRUk9pWEZTMDJxbk5vNHZic2dHT0NqUTBteWJTOVVZbTc0MUFtUFZHdnBuMXFUc21kS3pueTNaRFl5ZUJKMXBBeVpXQUk?oc=5","date":"2023-12-31","type":"pipeline","source":"BioSpace","summary":"Waves of Employee Cuts Hit Biopharma in 2023 - BioSpace","headline":"Waves of Employee Cuts Hit Biopharma in 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5sU2ZlWmdXTTUxUjYwaWpOOTBKU2JmazcyeU40YVREOFlPanBXUWc0T3B4eXNjdDZjNTRfNTJuLUJpS0RlcUk2VEFpcXg1RWk2Z3JYY3lqVkFldlhTUGFDOVRRaklUdWlYYXIzR0l6OUlkSThfYUJLbDJiQWg?oc=5","date":"2023-12-29","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2023: Reneo reduces workforce by 70%; Oxurion cuts staff down to 10 - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2023: Reneo reduces workforce by 70%; Oxurion cuts staff down to 10","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNT0xHdDNSZmZCRTRmejBVM3R5cUpNaHhWV0Nmb0dnNTgtc1pweW5UUzNTX09RVnA2Vjc4VjM2MzhCRGdHWVJmbDNOM0RzVjZZaGo2NGo4bmU2aUl5X3ZhOU00NDZTZGpNM1VyVzE4clFCZkdBY0ZlUU1lSlpwRHU5dnVMRnItSHhQdmZxRTVvUHk5cFZ0Y2xkclcwa2FmQV9pVTBUamJMT0VpYTNfdkprSUJ2WFRlcUI5UkpibGdn?oc=5","date":"2022-06-13","type":"pipeline","source":"Business Wire","summary":"Asher Bio Appoints Andrea Pirzkall, M.D., as Chief Medical Officer - Business Wire","headline":"Asher Bio Appoints Andrea Pirzkall, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQcnpqbDJ6OXZzVDlxOXRqVzdwQ1N0dDFYUk9mcnQtUm1LVjBvaFhwZ19hZWc1VW1LMDZkRjRJamt0RFhXc1JkSl8xcHBMX1VvOW8ta21VNDhkdElzTE0tQzdIQlVOMWZwNFlwaFFfYzNfcVA2VFo5OTZucTBRc1Q3ZG03RFFNaEVzdnpfOWFtZ0UtbTVuUlZudko0bUdTbHIwMU80QVpRMmhXZ2ZR?oc=5","date":"2021-10-24","type":"pipeline","source":"MedCity News","summary":"Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs - MedCity News","headline":"Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxObU5vNnRacThyYnZSNTFGSW5uWDlGNktIU1NGaTRCWDV0ZzNFdjAwMDZXVjZrdVZtTVR4dmNfdEd5ZkQxZG9rejZaaUdpWkoyWHJYNGpBa2NvYjBBSzVzTWh5RjlGZFNMY01nUi1vaVJmSGVMeTd0Yk9SdEtxMXhYZ0t3elI1akRfNzFxYnZmVFZwSi1GWXFTRERqUF9BczltdEJtVzlxTGp3OWNiS2tzRk9pQWgzT3hTQy1WSG1LTngxbUk?oc=5","date":"2021-09-01","type":"pipeline","source":"Fierce Biotech","summary":"Asher Bio snags $108M series B for immunotherapy programs, push into the clinic - Fierce Biotech","headline":"Asher Bio snags $108M series B for immunotherapy programs, push into the clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPd29PQV9Ma0JoUjlQeGswM0lJT1M0dVF0NnlHZXlPUjQ4eFVPLVFMcHcwR0U5NVFQdEN0LXJNM2ROXy1FdDVJZ2ZKMUZpZ2xtQ0RqcDJxdE5GM3Fya0pQZWlqQ2gwbVl5SjZvREI2Z3hDa0tZeUIxcG8wUXQzRUdGbTFybkx0OTRpNTNfVExqN1RneUtmWThZbVUzaFBmaEhUdC1QckMtLWc?oc=5","date":"2021-03-23","type":"pipeline","source":"MedCity News","summary":"Asher Bio adds $55M and takes a page from nature for cancer immunotherapy - MedCity News","headline":"Asher Bio adds $55M and takes a page from nature for cancer immunotherapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}